Earnings Call · Q1 FY2024·2024-05-13

Q1 24EPS +22.22%·Rev n/aQ4 23EPS +14.29%·Rev n/aQ3 23EPS +38.89%·Rev n/aQ2 23EPS +5.88%·Rev n/a⚠ consensus missing

Vaxart, Inc. VXRT

Edward Berg — Investor Relations or IR Representative

Steven Lo — Chief Executive Officer

James Cummings — Chief Medical Officer

Phillip Eric Lee — Chief Financial Officer

+5.5%1d on move date+5.0% vs SPY3d+24.4%5d+9.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VXRT calls or request research access.

More VXRT calls Browse calls Request research access